Healthcare Stocks Avoid Tariff Damage. There Are Other Problems. - Barron's
1. New tariffs on Canada and Mexico unlikely to impact PFE significantly. 2. Healthcare sector faces broader challenges, including drug pricing and Medicaid cuts. 3. PFE CEO stated manufacturing can shift to U.S. if necessary. 4. Healthcare sector up 8.5% this year despite various risks. 5. Smaller medical-device companies were affected more acutely by tariffs.